This research aims to improve outcomes for Intracerebral Haemorrhage (ICH) patients by developing new emergency treatments to reduce swelling in the brain after ICH, and improving the care that patients receive.
This research will investigate 2000 drugs that are already known to be safe for use in humans to see if they could help reduce the amount of damage to the brain which an intracerebral haemorrhage (a type of stroke caused by a bleed in the brain) causes.
People with stroke due to brain hemorrhage have swelling around the hemorrhage on their brain scan. This programme is about understanding the effect of blood on brain cells, with a focus on finding treatments.
Dr Banerjee aims to set up three studies to improve our understanding of how damaging proteins in the brain may increase the risk of stroke. This can lead the way for researchers to find out how we can help more people avoid damage to their brain caused by these proteins.
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage. This research on ICH will use zebrafish models so that we can gain a much better understanding of how cells of the brain respond to the bleeding and if there are ways that we can stop the damage caused.